Provided are: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2 a method for producing the antibody and a pharmaceutical composition containing the antibody for treating and/or preventing heterotopic ossification and/or osteodystrophy anemia or diffuse intrinsic pontine glioma (DIPG).